Clinical Trial Update: Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study [Phase 1]

View source ↗

Summary

A Phase 1b trial evaluating lenalidomide for Anti-MAG neuropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-mag Neuropathy
• Demyelinating Sensorimotor Neuropathy

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Ohio State University | Conditions: Demyelinating Sensorimotor Neuropathy | Phase 1 | Status: TERMINATED